Cargando…

The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers

PTEN, a putative tumour suppressor gene associated with prostate and other cancers, is known to be located within the chromosomal region 10q23.3. Transcription of the PTEN gives rise to multiple mRNA species. Analyses by Northern blots, using cell lines which express PTEN together with cell lines wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamilton, J A, Stewart, L M D, Ajayi, L, Gray, I C, Gray, N E, Roberts, K G, Watson, G J, Kaisary, A V, Snary, D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374512/ https://www.ncbi.nlm.nih.gov/pubmed/10817502 http://dx.doi.org/10.1054/bjoc.2000.1211

Ejemplares similares

Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.
por: Gray, I. C., et al.
Publicado: (1998)

Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas
por: Freihoff, D, et al.
Publicado: (1999)

Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma
por: Kulke, M H, et al.
Publicado: (2001)

A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1
por: Wilkinson, R W, et al.
Publicado: (2000)

Expression of the novel tumour suppressor p33(ING1) is independent of p53
por: Cheung, K-J J, et al.
Publicado: (2000)

Characterizing Variants of Unknown Significance of the PTEN tumour suppressorHomolog DAF-18
por: Ermakova, Glafira, et al.
Publicado: (2022)

Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor
por: Berenjeno, Inma M., et al.
Publicado: (2012)

Effects of indomethacin on expression of PTEN tumour suppressor in human cancers
por: Abdulkareem, Imran Haruna, et al.
Publicado: (2013)

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999)

Activation and activities of the p53 tumour suppressor protein
por: Bálint, É, et al.
Publicado: (2001)

Regulation of the tumor suppressor PTEN by SUMO
por: González-Santamaría, J, et al.
Publicado: (2012)

Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor
por: Albo, D, et al.
Publicado: (2000)

Tumour suppressor PTEN activity is differentially inducible by myo‐inositol phosphates
por: Grzymajlo, Krzysztof, et al.
Publicado: (2023)

The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer
por: Cook, A M, et al.
Publicado: (2000)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions
por: Miédougé, M, et al.
Publicado: (1999)

Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter–22q11.2
por: Hulsebos, T J M, et al.
Publicado: (1999)

Somatic mutation of PTEN in bladder carcinoma
por: Aveyard, J S, et al.
Publicado: (1999)

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
por: Cooper, R A, et al.
Publicado: (1999)

PTEN: Tumor Suppressor and Metabolic Regulator
por: Chen, Chien-Yu, et al.
Publicado: (2018)

Catalysis by the Tumor-Suppressor Enzymes PTEN and PTEN-L
por: Johnston, Sean B., et al.
Publicado: (2015)

Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li–Fraumeni syndrome
por: Burt, E C, et al.
Publicado: (1999)

Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas
por: Davies, M P A, et al.
Publicado: (1999)

Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer
por: Magdalena, C, et al.
Publicado: (2000)

Microsatellite instability in thyroid tumours and tumour-like lesions
por: Lazzereschi, D, et al.
Publicado: (1999)

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness
por: Wärnberg, F, et al.
Publicado: (2001)

Influence of tumour size on uptake of(111)In-DTPA-labelled pegylated liposomes in a human tumour xenograft model
por: Harrington, K J, et al.
Publicado: (2000)

Expression and association of IL-21, FBXL20 and tumour suppressor gene PTEN in laryngeal cancer
por: Yang, Qing, et al.
Publicado: (2019)

Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab́ fragments
por: Casey, J L, et al.
Publicado: (1999)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Comparative genomic hybridization and chromosomal instability in solid tumours
por: Rooney, P H, et al.
Publicado: (1999)

The effects of hyperoxic and hypercarbic gases on tumour blood flow
por: Dunn, T J, et al.
Publicado: (1999)

In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
por: Veen, A H van der, et al.
Publicado: (1999)

Biologic markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size
por: Sauter, E R, et al.
Publicado: (1999)

Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue
por: Luo, L-Y, et al.
Publicado: (2001)

Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ
por: Bijker, N, et al.
Publicado: (2001)

Igf2 ligand dependency of Pten(+/−) developmental and tumour phenotypes in the mouse
por: Church, D N, et al.
Publicado: (2012)

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001)

Thalidomide increases both intra-tumoural tumour necrosis factor-α production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid
por: Cao, Z, et al.
Publicado: (1999)

Minisatellite instability is found in colorectal tumours with mismatch repair deficiency
por: Coleman, M G, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_uq2m1ilcko9d01fjdt19amk35v